dc.contributor.author | Σούλπη, Κλεοπάτρα | el |
dc.contributor.author | Καρίκας, Γεώργιος-Αλβέρτος | el |
dc.contributor.author | Μπαρτζελιώτου, Αναστασία | el |
dc.contributor.author | Παπακωνσταντίνου, Ευάγγελος Δ. | el |
dc.contributor.author | Καλογεράκου, Μαρία | el |
dc.date.accessioned | 2015-05-08T00:08:50Z | |
dc.date.available | 2015-05-08T00:08:50Z | |
dc.date.issued | 2015-05-08 | |
dc.identifier.uri | http://hdl.handle.net/11400/9908 | |
dc.rights | Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.source | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2265.2007.02946.x/abstract | en |
dc.subject | επιδράσεις της δίαιτας | |
dc.subject | αντιαρτηριοσκληρωτικό ένζυμο | |
dc.subject | Παραοξονάση | |
dc.subject | Αρυλεστεράση | |
dc.subject | μεταβολισμός | |
dc.subject | γαλακτόζη | |
dc.subject | effects of diet | |
dc.subject | antiatherogenic enzyme | |
dc.subject | Paraoxonase | |
dc.subject | arylesterase | |
dc.subject | metabolism | |
dc.subject | galactose | |
dc.title | The effect of diet on Paraoxonase 1/Arylesterase activities in patients with disorders of galactose metabolism | en |
heal.type | journalArticle | |
heal.classification | Κλινική βιοχημεία | |
heal.classification | Ενδοκρινολογία | |
heal.classification | Clinical biochemistry | |
heal.classification | Endocrinology | |
heal.classificationURI | **N/A**-Κλινική βιοχημεία | |
heal.classificationURI | **N/A**-Ενδοκρινολογία | |
heal.classificationURI | http://id.loc.gov/authorities/subjects/sh85027062 | |
heal.classificationURI | http://id.loc.gov/authorities/subjects/sh2002006108 | |
heal.keywordURI | http://id.loc.gov/authorities/subjects/sh2002008729 | |
heal.keywordURI | http://lod.nal.usda.gov/12712 | |
heal.keywordURI | http://lod.nal.usda.gov/6219 | |
heal.contributorName | Τσακίρης, Στυλιανός | el |
heal.identifier.secondary | DOI: 10.1111/j.1365-2265.2007.02946.x | |
heal.language | en | |
heal.access | free | |
heal.recordProvider | Τεχνολογικό Εκπαιδευτικό Ίδρυμα Αθήνας. Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Ιατρικών Εργαστηρίων | el |
heal.publicationDate | 2007-11 | |
heal.bibliographicCitation | Schulpis, K.H., Karikas, G.A., Bartzeliotou, A., Papakonstantinou, E.D., Kalogerakou, M. et al. (2007) The effect of diet on Paraoxonase 1/Arylesterase activities in patients with disorders of galactose metabolism. Clinical Endocrinology. [Online] 67 (5). pp.687-692. Available from: http://onlinelibrary.wiley.com [Accessed 07/05/2015] | en |
heal.abstract | Objective To investigate the effects of diet on the antiatherogenic enzyme Paraoxonase 1/Arylesterase (PON1/Aryl) activities in patients with disorders of galactose metabolism. Patients and methods Eleven poorly dietary controlled children with classical galactosaemia (GALT deficiency), 7 with epimerase deficiency and 12 with duarte 1 variant ‘off diet’ underwent clinical and laboratory investigations before and after 10 days on galactose restricted diet whereas controls (N = 20) were examined once. Serum lipids, lipoproteins and apolipoprotein A1 (ApoA1) were measured with routine methods, PON1/Aryl activities and total antioxidant status (TAS) spectrophotometrically, and galactose-1-phosphate (Gal-1-P) enzymatically. Results Lipids, lipoproteins, ApoA1, PON1/Aryl, TAS remained unaltered in all groups, except in those with classical galactosaemia pre- versus postdiet. In patients with classical galactosaemia, TAS, PON1, Aryl (0·98 ± 0·2 mmol/l, 60 ± 12 U/min/ml, 56 ± 16 KU/min/ml, respectively) were significantly reduced prediet as compared with those postdiet (1·63 ± 0·2 mmol/l, 136 ± 15 U/min/ml, 112 ± 18 KU/min/ml, respectively; P < 0·001) and controls. The enzyme activities positively correlated with TAS (r = 0·56, P < 0·001) in all groups and negatively with Gal-1-P (r = –0·54, P < 0·001) in group with GALT deficiency. Conclusions Low TAS and high Gal-1-P levels may reduce PON1/Aryl activities. Patients with classical galactosaemia, when on strict diet, may benefit with a generous antiatherogenic capacity. | en |
heal.journalName | Clinical Endocrinology | en |
heal.journalType | peer-reviewed | |
heal.fullTextAvailability | true |
Οι παρακάτω άδειες σχετίζονται με αυτό το τεκμήριο: